Event-Driven Stocks

Electromed, Inc.

ELMDNYSE

Healthcare · Electromedical & Electrotherapeutic Apparatus · MN · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 7 gooddetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$64.0M$54.7M$48.1M$41.7M$35.8M$32.5M
Operating income$9.7M$6.6M$4.0M$3.0M$3.1M$5.1M
Net income$7.5M$5.2M$3.2M$2.3M$2.4M$4.2M
Total assets$53.8M$52.2M$45.8M$41.4M$37.1M$33.2M
Total liabilities$10.6M$7.7M$8.1M$7.2M$4.7M$3.0M
Equity$43.2M$44.5M$37.7M$34.2M$32.4M$30.3M
EPS (diluted)$0.85$0.58$0.36$0.26$0.27$0.47
Shares out.8.3M8.6M8.6M8.5M8.6M8.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
15.1%
Net margin
11.8%
Return on equity
17.4%
Return on assets
14.0%
Return on capital (ROCE)
22.3%
Liabilities / assets
19.7%
Debt / equity
0.25×
Book value / share
$5.18
Revenue growth (YoY)
17.0%
Net income growth (YoY)
46.3%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
10.99safe
Accruals / assets
−7.2%clean
Beneish M-Score
-2.76normal
Piotroski F-Score
7/9strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
93
/ 100
Profitability 100Growth 100Catalyst 67Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 7 good
  • Operating margin is positive
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026139,3531.8-23.1%
Apr 30, 2026181,2466.2+12.2%
Apr 15, 2026161,6154.7-15.1%
Mar 31, 2026190,4333.3+12.1%
Mar 13, 2026169,9523.3-4.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.